Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
Clinical trial NCT02669667 · COMPLETED
Trial details
- NCT number
- NCT02669667
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-18
- Primary completion
- 2016-11-17
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.